Borrelia burgdorferi infection is common in horses living in Lyme endemic areas and the geographic range for exposure is increasing. Morbidity after B. burgdorferi infection in horses is unknown. Documented, naturally occurring syndromes attributed to B. burgdorferi infection in horses include neuroborreliosis, uveitis, and cutaneous pseudolymphoma. Although other clinical signs such as lameness and stiffness are reported in horses, these are often not well documented. Diagnosis of Lyme disease is based on exposure to B. burgdorferi, cytology or histopathology of infected fluid or tissue and antigen detection. Treatment of Lyme disease in horses is similar to treatment of humans or small animals but treatment success might not be the same because of species differences in antimicrobial bioavailability and duration of infection before initiation of treatment. There are no approved equine label Lyme vaccines but there is strong evidence that proper vaccination could prevent infection in horses.

BackgroundEquine neuroborreliosis (NB), Lyme disease, is difficult to diagnose and has limited description in the literature.ObjectiveProvide a detailed description of clinical signs, diagnostic, and pathologic findings of horses with NB.AnimalsSixteen horses with histologically confirmed NB.MethodsRetrospective review of medical records at the University of Pennsylvania and via an ACVIM listserv query with inclusion criteria requiring possible exposure to Borrelia burgdorferi and histologic findings consistent with previous reports of NB without evidence of other disease.ResultsSixteen horses were identified, 12 of which had additional evidence of NB. Clinical signs were variable including muscle atrophy or weight loss (12), cranial nerve deficits (11), ataxia (10), changes in behavior (9), dysphagia (7), fasciculations (6), neck stiffness (6), episodic respiratory distress (5), uveitis (5), fever (2), joint effusion (2), and cardiac arrhythmias (1). Serologic analysis was positive for B. burgdorferi infection in 6/13 cases tested. CSF abnormalities were present in 8/13 cases tested, including xanthochromia (4/13), increased total protein (5/13; median: 91 mg/dL, range: 25–219 mg/dL), and a neutrophilic (6/13) or lymphocytic (2/13) pleocytosis (median: 25 nucleated cells/μL, range: 0–922 nucleated cells/μL). PCR on CSF for B. burgdorferi was negative in the 7 cases that were tested.Conclusion and Clinical ImportanceDiagnosis of equine NB is challenging due to variable clinical presentation and lack of sensitive and specific diagnostic tests. Negative serology and normal CSF analysis do not exclude the diagnosis of NB.

Introduction: Lung cancer survivors are at high risk of developing a second primary lung cancer (SPLC). However, SPLC risk factors have not been established and the impact of tobacco smoking remains controversial. We examined the risk factors for SPLC across multiple epidemiologic cohorts and evaluated the impact of smoking cessation on reducing SPLC risk.Methods: We analyzed data from 7059 participants in the Multiethnic Cohort (MEC) diagnosed with an initial primary lung cancer (IPLC) between 1993 and 2017. Cause-specific proportional hazards models estimated SPLC risk. We conducted validation studies using the Prostate, Lung, *Corresponding author. Disclosure: Dr. Kurian reports receiving research funding to the institution from Myriad Genetics outside of the submitted work. Dr. Wakelee reports receiving personal consulting fees from Janssen, Daiichi Sankyo, Helsinn, Mirati, AstraZeneca, and Blueprint and grants to institution for clinical trial conduct from ACEA Biosciences, Arrys

No abstract

A total of 433 Holstein heifer calves were fed two different energy amounts from 6 wk of age to breeding weight to determine the effect of early nutrition and age at first calving on lifetime performance. A control group of 182 heifers was fed according to the Beltsville growth standard. A second group of 251 heifers was accelerated in growth by providing more energy during early development. Both groups of heifers were bred at a minimum weight of 340 kg. Average ages at first calving for control and accelerated heifers were 24.6 mo and 22.2 mo with corresponding 305-d first lactation unadjusted milk production values of 6985 and 6729 kg and unadjusted milk fat yields of 222 and 216 kg. Average 305-d milk production values through subsequent lactations for control and accelerated animals, were lactation 2, 7790, 7842 kg; lactation 3, 8200, 8330 kg; lactation 4, 9481, 9134 kg; lactation 5, 9865, 9588 kg; lactation 6, 9515, 10,108; lactation 7, 9661, 10,112. Average total milk yields over five lactations were 42,321 and 41,623 kg. Percentages of cows remaining in the herd after five lactations were 19 and 18 for control and accelerated animals. Reproductive problems, mastitis, and deaths accounted for 70% of cows leaving the herd and did not differ between treatment groups.

Feeding for 150 days of 25 g per day of methionine hydroxy analog was tested on 100 cows (52 treated and 48 controls) in the Brigham Young University herd. Effect of days after parturition of initiating methionine hydroxy analog feeding also was observed. Milk yields were not affected by methionine hydroxy analog, but fat percent and fat yields were increased 21 and 17% by the additive. Abnormally low milk fat by control cows (2.84%) magnified the response to methionine hydroxy analog feeding. Feeding methionine hydroxy analog beginning 0 to 12 days postpartum elicited much larger increases of milk fat than started later (17 to 102 days). Blood from the coccygeal vein of 20 cows from each treatment had 10% more triglycerides from cows fed methionine hydroxy analog than from control cows. Increases of arterio-venous differences across the mammary gland of triglycerides and lipoproteins of blood serum suggested that increases of milk fat could have resulted from greater uptake of performed fat by the udder. Feeding methionine hydroxy analog increased methionine, isoleucine, and leucine in serum of coccygeal vein, but methionine was the only amino acid with significantly higher arteriovenous differences across the mammary gland.

BackgroundThe practice of antenatal breast expression (ABE) has been proposed as a strategy to promote successful breastfeeding. Although there has been some focus on the evaluation of the effects of ABE in promotion of breastfeeding, little or no evidence exists on women’s experiences of ABE or opinions on ABE, particularly amongst overweight or obese women.MethodsThis study aimed to explore women’s knowledge, practices and opinions of ABE, and any differences within the overweight and obese subgroups. A cross-sectional survey was undertaken using an online questionnaire distributed by a maternity user group representative via social media. Quantitative data were analysed using Chi-square and Fisher’s exact tests in SPSS. Simple thematic analysis was used for the qualitative data.ResultsA total of 688 responses were analysed; the sample represented a group of breastfeeding mothers, of whom 64.5% had heard of ABE, 8.2% had been advised to do ABE, and 14.2% had undertaken ABE. Of the women who had been advised to do ABE, 67.9% had complied. Most participants (58.6%) were unsure if ABE was a good idea; however 80.9% would consider doing ABE if it was found to be helpful to prepare for breastfeeding. Women in the overweight or obese subgroups were significantly more likely to have heard of ABE (p < 0.001), and positive opinion of ABE also increased with higher BMI groups. The qualitative data demonstrated participants felt ABE may be beneficial when mother or baby have medical problems, and in preparation for breastfeeding, but highlighted their concerns that it may interfere with nature and be harmful, and that they wanted more information and knowledge about ABE.ConclusionsAmongst women who have breastfed, many have heard of ABE, compliance with advice to undertake ABE is relatively high, and ABE is considered an acceptable practice. Further investigation into the benefits and safety of ABE is warranted, to address the needs of childbearing women for evidence-based information about this practice. If the evidence base is established, overweight and obese pregnant women could be an important target group for this intervention.Electronic supplementary materialThe online version of this article (10.1186/s12978-018-0497-4) contains supplementary material, which is available to authorized users.

No abstract